0001209191-21-049165.txt : 20210802
0001209191-21-049165.hdr.sgml : 20210802
20210802213651
ACCESSION NUMBER: 0001209191-21-049165
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210729
FILED AS OF DATE: 20210802
DATE AS OF CHANGE: 20210802
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Whitfill Travis
CENTRAL INDEX KEY: 0001830178
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39692
FILM NUMBER: 211137661
MAIL ADDRESS:
STREET 1: C/O IN8BIO,INC.
STREET 2: 79 MADISON AVENUE
CITY: NEW YORK
STATE: NY
ZIP: 10016
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: IN8BIO, INC.
CENTRAL INDEX KEY: 0001740279
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 825462585
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 79 MADISON AVENUE, 2ND FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10016
BUSINESS PHONE: (646) 600-6438
MAIL ADDRESS:
STREET 1: 79 MADISON AVENUE, 2ND FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10016
FORMER COMPANY:
FORMER CONFORMED NAME: Incysus Therapeutics, Inc.
DATE OF NAME CHANGE: 20180510
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-07-29
0
0001740279
IN8BIO, INC.
INAB
0001830178
Whitfill Travis
C/O IN8BIO, INC.
79 MADISON AVENUE
NEW YORK
NY
10016
1
0
0
0
Stock Option (right to buy)
10.00
2021-07-29
4
A
0
10500
0.00
A
2031-07-29
Common Stock
10500
10500
D
One twelfth (1/12th) of the shares subject to the option shall vest in equal monthly installments commencing on August 29, 2021 and will be fully vested on the date of the next annual meeting of the Issuer's stockholders, subject to the Reporting Person continuing to provide service through each such date. The Reporting Person disclaims beneficial ownership of the option except to the extent of his pecuniary interest therein.
/s/ Jason Minio, Attorney-in-Fact
2021-08-02